180 related articles for article (PubMed ID: 35269944)
1. Dickkopf-1 Promotes Angiogenesis and is a Biomarker for Hepatic Stem Cell-like Hepatocellular Carcinoma.
Suda T; Yamashita T; Sunagozaka H; Okada H; Nio K; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269944
[TBL] [Abstract][Full Text] [Related]
2. Human amniotic mesenchymal stem cells inhibit hepatocellular carcinoma in tumour-bearing mice.
Liu QW; Li JY; Zhang XC; Liu Y; Liu QY; Xiao L; Zhang WJ; Wu HY; Deng KY; Xin HB
J Cell Mol Med; 2020 Sep; 24(18):10525-10541. PubMed ID: 32798252
[TBL] [Abstract][Full Text] [Related]
3. Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma.
Kim SU; Park JH; Kim HS; Lee JM; Lee HG; Kim H; Choi SH; Baek S; Kim BK; Park JY; Kim DY; Ahn SH; Lee JD; Han KH
Yonsei Med J; 2015 Sep; 56(5):1296-306. PubMed ID: 26256972
[TBL] [Abstract][Full Text] [Related]
4. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
[TBL] [Abstract][Full Text] [Related]
5. Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma.
Sawahara H; Shiraha H; Uchida D; Kato H; Kato R; Oyama A; Nagahara T; Iwamuro M; Horiguchi S; Tsutsumi K; Mandai M; Mimura T; Wada N; Takeuchi Y; Kuwaki K; Onishi H; Nakamura S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Yagi T; Nasu Y; Kumon H; Okada H
J Gastroenterol Hepatol; 2017 Oct; 32(10):1769-1777. PubMed ID: 28168749
[TBL] [Abstract][Full Text] [Related]
6. Dickkopf-1: as a diagnostic and prognostic serum marker for early hepatocellular carcinoma.
Yang H; Chen GD; Fang F; Liu Z; Lau SH; Zhang JF; Lau WY; Yang LY
Int J Biol Markers; 2013 Sep; 28(3):286-97. PubMed ID: 23568769
[TBL] [Abstract][Full Text] [Related]
7. Serum REIC/Dickkopf-3 Protein Level Predicts Disease-Free Survival in Patients with Hepatocellular Carcinoma.
Oyama A; Uchida D; Shiraha H; Sawahara H; Kato R; Iwamuro M; Horiguchi S; Okada H
Acta Med Okayama; 2020 Jun; 74(3):237-243. PubMed ID: 32577022
[TBL] [Abstract][Full Text] [Related]
8. Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma.
Sun XT; Yuan XW; Zhu HT; Deng ZM; Yu DC; Zhou X; Ding YT
World J Gastroenterol; 2012 Sep; 18(35):4925-33. PubMed ID: 23002366
[TBL] [Abstract][Full Text] [Related]
9. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
[TBL] [Abstract][Full Text] [Related]
10. DLK1 as a potential target against cancer stem/progenitor cells of hepatocellular carcinoma.
Xu X; Liu RF; Zhang X; Huang LY; Chen F; Fei QL; Han ZG
Mol Cancer Ther; 2012 Mar; 11(3):629-38. PubMed ID: 22238367
[TBL] [Abstract][Full Text] [Related]
11. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
[TBL] [Abstract][Full Text] [Related]
12. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Dickkopf-1 predicts poor prognosis for patients with hepatocellular carcinoma after orthotopic liver transplantation by promoting cancer metastasis and recurrence.
Huang Y; Yang X; Zhao F; Shen Q; Wang Z; Lv X; Hu B; Yu B; Fan J; Qin W
Med Oncol; 2014 Jul; 31(7):966. PubMed ID: 24878698
[TBL] [Abstract][Full Text] [Related]
14. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
15. Preliminary mechanism on the methylation modification of Dkk-1 and Dkk-3 in hepatocellular carcinoma.
Liang L; He H; Lv R; Zhang M; Huang H; An Z; Li S
Tumour Biol; 2015 Feb; 36(2):1245-50. PubMed ID: 25344678
[TBL] [Abstract][Full Text] [Related]
16. The possible role of Dickkopf-1, Golgi protein- 73 and Midkine as predictors of hepatocarcinogenesis: a review and an Egyptian study.
N Zekri AR; El Kassas M; Salam ESE; Hassan RM; Mohanad M; Gabr RM; M Lotfy M; Abdel-Zaher RAT; Bahnassy AA; Ahmed OS
Sci Rep; 2020 Mar; 10(1):5156. PubMed ID: 32198440
[TBL] [Abstract][Full Text] [Related]
17. Aberrant LYZ expression in tumor cells serves as the potential biomarker and target for HCC and promotes tumor progression via csGRP78.
Gu Z; Wang L; Dong Q; Xu K; Ye J; Shao X; Yang S; Lu C; Chang C; Hou Y; Zhai Y; Wang X; He F; Sun A
Proc Natl Acad Sci U S A; 2023 Jul; 120(29):e2215744120. PubMed ID: 37428911
[TBL] [Abstract][Full Text] [Related]
18. Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
Huang T; Guo YZ; Yue X; Zhang GP; Zhang Y; Kuang M; Peng BG; Li SQ
Carcinogenesis; 2020 Jul; 41(5):571-581. PubMed ID: 32649753
[TBL] [Abstract][Full Text] [Related]
19. Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
Huang T; Guo YZ; Yue X; Zhang GP; Zhang Y; Kuang M; Peng BG; Li SQ
Carcinogenesis; 2020 Jul; 41(5):571-581. PubMed ID: 32648918
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of Dkk-3 decreases cancer cell migration and invasion independently of the Wnt pathways in oral squamous cell carcinoma‑derived cells.
Katase N; Lefeuvre M; Tsujigiwa H; Fujii M; Ito S; Tamamura R; Buery RR; Gunduz M; Nagatsuka H
Oncol Rep; 2013 Apr; 29(4):1349-55. PubMed ID: 23354949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
